References
- Ellenhorn M J, Barceloux DG. Iron. Medical Toxicology, Diagnosis and Treatment of Human Poisoning. Elsevier, New York 1988; 1023–1030
- Robotham J L, Leitman PS. Acute iron poisoning. A review. Am J Dis Child 1980; 134: 875–879
- Eisen T F, Lacouture P G, Woolf A. Visual detection of ferrioxamine color changes in urine. Vet Hum Toxicol 1988; 30: 369–370
- Gevirtz N R, Wasserman LR. The measurement of iron and iron-binding capacity in plasma containing deferoxamine. J Pediatr 1966; 68: 802–804
- Heifer R E, Rogerson DO. The effect of deferoxamine on the determination of serum iron and iron-binding capacity. J Pediatr 1966; 68: 804–806
- Steinmetz W L, Glick M R, Oei TO. Modified aca method for determination of iron chelated by deferoxamine and other chelators. Clin Chem 1980; 26: 1593–1597
- Moeschlin S, Schnider U. Treatment of primary and secondary hemochromatosis and acute iron poisoning with a new, potent iron-eliminating agent (desferrioxamine-B). New Engl J Med 1963; 269: 57–66
- Ramsay W NM. The determination of the total iron binding capacity of the serum. Clin Chem Acta 1957; 2: 221–226
- Piomelli S, Davidow B, Guinee V F, Young P, Gay G. The FEP (free erythrocyte protoporphyrin) test: a screening micromethod for lead poisoning. Pediatrics 1973; 51: 254–259
- Ginsberg J M, Chang B S, Matarese R A, Garella S. Use of single voided urine samples to estimate quantitative proteinuria. New Engl J Med 1983; 309: 1543–1546
- Moore E S, Coe F L, McMann B J, Favus MJ. Idiopathic hypercalcemia in children. Prevalence and metabolic characteristics. J Pediatr 1978; 92: 906–910